PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
78.42
-0.17 (-0.22%)
Jul 20, 2026, 10:19 AM EDT - Market open
PTC Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $124 → $130 | Buy | Reiterates | $124 → $130 | +65.77% | Jul 16, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $93 → $95 | Buy | Reiterates | $93 → $95 | +21.14% | Jul 15, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $89 → $91 | Buy | Maintains | $89 → $91 | +16.04% | Jul 13, 2026 |
| Barclays | Barclays | Buy Maintains $120 | Buy | Maintains | $120 | +53.02% | Jul 8, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $82 → $85 | Hold | Maintains | $82 → $85 | +8.39% | Jul 7, 2026 |
| Citi | Citi | Buy Initiates $75 → $108 | Buy | Initiates | $75 → $108 | +37.72% | Jun 9, 2026 |
| Jefferies | Jefferies | Buy Upgrades $76 → $85 | Buy | Upgrades | $76 → $85 | +8.39% | May 27, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $92 → $94 | Buy | Maintains | $92 → $94 | +19.87% | May 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.